Condition
Neonatal Infections
Total Trials
6
Recruiting
0
Active
1
Completed
4
Success Rate
80.0%-7% vs avg
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
80.0%
-6.5% vs benchmark
Late-Stage Pipeline
33%
2 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
80% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 3 (1)
P 4 (1)
Trial Status
Completed4
Active Not Recruiting1
Terminated1
Trial Success Rate
80.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06758622Active Not Recruiting
Analysis on the Health of Newborns in Three Hospitals, 2008-2024
NCT01214473Not ApplicableTerminated
Probiotics for Prevention Neonatal Infection
NCT00743691Not ApplicableCompletedPrimary
Impact Study of Community Based Treatment of Neonatal Infection by Health Extension Workers on Neonatal Mortality
NCT02279381Phase 4CompletedPrimary
Neonatal Package Study in Rural District of Pakistan
NCT00920530CompletedPrimary
Real-Time PCR for the Detection of Vaginal Group B Streptococcus Carriage: a Medico-Economic Study
NCT00713726Phase 3Completed
Tramadol Versus Fentanyl for Post-Operative Analgesia in Newborn Infants
Showing all 6 trials